Evidence map›Paper›PMID 33454829›Full record

Observational studyDiabetologia2021

Poor glycaemic control is associated with increased risk of neurodevelopmental disorders in childhood-onset type 1 diabetes: a population-based cohort study.

Shengxin Liu, Ralf Kuja-Halkola, Henrik Larsson, Paul Lichtenstein, Jonas F Ludvigsson, Ann-Marie Svensson, Soffia Gudbjörnsdottir, Magnus Tideman, Eva Serlachius, Agnieszka Butwicka

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Diabetologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Shengxin LiuDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden. Shengxin.liu@ki.se.
Ralf Kuja-HalkolaDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.
Henrik LarssonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.
Paul LichtensteinDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.
Jonas F LudvigssonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.
Ann-Marie SvenssonSwedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden.
Soffia GudbjörnsdottirSwedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden.
Magnus TidemanSchool of Health and Welfare, Halmstad University, Halmstad, Sweden.
Eva SerlachiusChild and Adolescent Psychiatry, Stockholm Health Care Service, Region Stockholm, Sweden.
Agnieszka ButwickaDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.
Karolinska Institutet · SECentre of Registers Vastra Gotaland · SEStockholm Health Care Services · SEColumbia University · USHalmstad University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisThe aim of this study was to investigate the effect of childhood-onset type 1 diabetes on the risk of subsequent neurodevelopmental disorders, and the role of glycaemic control in this association. We hypothesised that individuals with poor glycaemic control may be at a higher risk of neurodevelopmental disorders compared with the general population, as well as compared with individuals with type 1 diabetes with adequate glycaemic control.

methodsThis Swedish population-based cohort study was conducted using data from health registers from 1973 to 2013. We identified 8430 patients with childhood-onset type 1 diabetes (diagnosed before age 18 years) with a median age of diabetes onset of 9.6 (IQR 5.9-12.9) and 84,300 reference individuals from the general population, matched for sex, birth year and birth county. Cox models were used to estimate the effect of HbA

resultsDuring a median follow-up period of 5.6 years, 398 (4.7%) individuals with type 1 diabetes received a diagnosis of any neurodevelopmental disorder compared with 3066 (3.6%) in the general population, corresponding to an adjusted HR (HR CONCLUSIONS/

interpretationChildhood-onset type 1 diabetes is associated with an increased risk of neurodevelopmental disorders, with the highest risk seen in individuals with poor glycaemic control. Routine neurodevelopmental follow-up visits should be considered in type 1 diabetes, especially in patients with poor glycaemic control.

Indexed as

Glycemic ControlAdolescentBiomarkersBlood GlucoseChildDiabetes Mellitus, Type 1FemaleGlycated HemoglobinHumansLongitudinal StudiesMaleNeurodevelopmental DisordersPrognosisProspective StudiesRegistriesRisk AssessmentBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanAttention-deficit/hyperactivity disorderAutism spectrum disordersGlycaemic controlIntellectual disabilityNeurodevelopmental disordersType 1 diabetes

Identifiers

PMID33454829
PMCPMC7940269
OpenAlexW3123963345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.